Study Links Vaping to Irregular Heartbeats in Mice

Nov.03.2022
Study Links Vaping to Irregular Heartbeats in Mice
A study on e-cigarette liquids causing heart rhythm disruption in mice is criticized for its lack of relevance to humans.

A newspaper has reported on a study claiming that electronic cigarette liquid can disrupt heart rhythms, but has failed to highlight that the study was conducted on mice and involved toxic doses. An expert on tobacco reduction has pointed out that the only information this study provides is that "pet mouse owners should not allow their mice to use electronic cigarettes.


According to The Independent, a new study has found that using e-cigarette fluids containing certain ingredients can cause heart rhythm irregularities, thereby increasing the risk of heart attacks.


A recent study published in Nature Communications suggests that e-cigarettes and their individual components can cause irregular heart rhythms and conduction defects in mice. The researchers conducted electrocardiogram tests on mice after acute inhalation of e-cigarette vapors. They argue that "our findings suggest that the chemical composition of e-cigarettes may increase cardiac risk by inducing changes that promote arrhythmogenesis and stimulate autonomic reflexes.


Experts in tobacco harm reduction and e-cigarettes quickly criticized the study. Professor Jacob George, Head of Cardiovascular Medicine and Therapeutics at the University of Dundee Medical School, said: "The metabolism of mice is very different from that of humans, and to be honest, any inference to long-term human health effects are at best speculative. If this were indeed true, given the large number of e-cigarette users worldwide, we would have expected to see a dramatic increase in cases of arrhythmia, which we have not seen in clinical practice.


The controversial nature of e-cigarettes brings into question the preliminary and speculative science surrounding its potential impact on human health, including the effects of nicotine on blood vessels. However, large-scale observational studies of users of nicotine replacement therapy have shown no increase in heart events. These findings should not deter those seeking to quit smoking from attempting e-cigarettes or nicotine replacement therapy. This early-stage preclinical research requires further clinical work before it can be considered directly related to human health.


Professor Peter Hajek, director of the Tobacco Dependence Research Department at Queen Mary University of London, added that "in this study, mice were exposed to aerosols from e-cigarette solvents with and without nicotine, as well as acrolein (a chemical that may be produced due to overheating) in e-cigarette liquid. Such exposure was associated with short-term changes in the mice's electrocardiograms and an increase in heart rate.


When talking about applying the results of this study to humans, there are several issues to consider. Electronic cigarette users are unlikely to be exposed to significant levels of acrolein since overheated e-liquid produces an unpleasant taste that people tend to avoid. While the study used exposure levels to other chemicals that humans can tolerate, the same dose may cause significant pain in much smaller mammals with more sensitive olfactory systems and varying tolerances to medication. It would be strange if animals exposed to aversive stimuli did not show a cardiovascular response. The reason for using mice in this study remains unclear. When experiments cannot be conducted on humans, animal models may be used, but comparing heart rate and electrocardiograms for electronic cigarette components and human smoking reactions is not without hurdles.


Professor Kevin McConway, Honorary Professor of Applied Statistics at The Open University in the UK, continues to criticize and has released a detailed statement saying: "As a statistician and not a biologist, I am unable to comment on the physiological details of this study. However, in my view, most aspects of the statistical analysis of the experimental results are reliable, and the study provides good evidence that certain components of e-cigarettes do indeed affect some aspects of mouse heart function when the mice are exposed to these components in the way done in this study. Nevertheless, while I believe that investigating the potential harmful effects of e-cigarette components is certainly worthwhile, and I also believe that animal experiments can play a role in this work, this work cannot answer some important questions.


I don't believe any knowledgeable commentator has suggested that using e-cigarettes is without risk. The important question is how the harm of using e-cigarettes compares to the harm that would result if the person did not use them. This, of course, depends on what the person would do if they did not use e-cigarettes. If they are a traditional smoker and e-cigarettes help them quit, then using e-cigarettes would prevent greater harm from their previous smoking habit. Other studies have shown that e-cigarettes can effectively help people quit smoking and are often more effective than nicotine replacement therapy like patches or gum. So, when used by smokers, the real question is not whether e-cigarettes are completely harmless, but whether they are safer than continuing to smoke or using other methods to quit, which may be less effective. This new study does not shed light on that question, and there is no evidence in its findings to suggest that using e-cigarettes is as harmful as smoking regular cigarettes, even in mice.


For those who are not yet smokers, electronic cigarette companies say it may be different. However, people still need to consider whether using electronic cigarettes may lead to other dangerous habits, such as using different drugs.


To the best of my understanding, this study has the potential to distinguish the effects of different components in e-cigarettes to some extent, which is an advantage. For example, this could lead to the development of safer e-cigarettes. However, as noted by the researchers, the reactions to various chemicals observed in mice may not necessarily apply to humans, even though this study specifically looks at several components of e-cigarettes and their potential effects on mice. Therefore, there is still a lot of work to be done and all relevant factors must be taken into consideration.


In addition, the study used a very small number of female mice - only four - and these mice did not come into contact with most of the substances involved. This means that, as the researchers have themselves acknowledged, some of the potential conclusions about gender differences are not based on evidence. Finally, these mice were (of course) completely unfamiliar with e-cigarettes, and the researchers note that the effects may be very different for individuals who have experience with e-cigarettes or tobacco use.


Dr. Adam Jacobs, Senior Director of Biostatistics at Premier Research, provided commentary on the study, stating "This study suggests that mice exposed to e-cigarette aerosol in a closed space for 90 minutes experience short-term changes in heart rhythm. While the long-term effects of these changes are not yet clear, it seems prudent for pet owners to avoid exposing their rodents to e-cigarettes. For humans, while e-cigarettes cannot be considered completely safe, there is a significant amount of evidence showing it to be much safer than smoking combustible cigarettes. Therefore, smokers who switch from traditional cigarettes to e-cigarettes will greatly reduce their health risks.


Statement:


The content of this article is compiled from third-party information and is only intended for industry exchange and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of its content. The translation of this article is only intended for industry communication and research purposes.


Due to limitations in the translator's skills, the translated article may not fully express the same meaning as the original text. Please refer to the original text for accuracy.


2FIRSTS remains completely aligned with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us to request removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Indonesia's Influential Islamic Body MUI Urges Vape Permit Freeze, Raising Uncertainty for 200 Manufacturers
Indonesia's Influential Islamic Body MUI Urges Vape Permit Freeze, Raising Uncertainty for 200 Manufacturers
Indonesia's Ulema Council (MUI) published Fatwa No. 131/2026 on November 9, declaring electronic cigarette use, production and trade haram under Islamic religious rules. The council urged the Industry Ministry to prohibit the issuance of vape industry permits and review licensing policies, while calling on the president and parliament to enact a comprehensive ban. On November 10, the Constitutional Court heard a challenge to provisions of the 2023 Health Law seeking a prohibition on vape production, importation, distribution and use. The Health Ministry said on November 11 it was studying stronger restrictions, including a possible ban on circulation, while industry association APVI called for tighter oversight rather than a total ban. Indonesia's Industry Ministry previously estimated the sector comprises about 200 companies, Rp31 trillion ($1.7 billion) in cumulative investment and approximately 100,000 supply-chain jobs. No nationwide statutory ban has been enacted.
Regulations
Nov.12
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
A U.S. International Trade Commission (USITC) administrative law judge issued an initial determination on October 20, 2026, finding that certain Glas vaping devices, cartridges and components infringed 12 claims across two patents asserted by JUUL, constituting a violation of Section 337 of the Tariff Act of 1930. The judge recommended a limited exclusion order and a cease and desist order against the Glas respondents. Five months earlier, the FDA authorized four Glas e-cigarette pods, including mango, blueberry and two menthol variants. The patent investigation concerns device and cartridge structures and is separate from FDA premarket review. The proposed import restrictions have not become final, and their product-level scope remains unresolved.
company
Nov.05
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
U.S. nicotine pouch startup Skoka Inc. has raised $21.5 million and committed $15 million to an FDA regulatory and scientific research program. Founder Dan Aziz previously built dietary supplement brand Premama, which was acquired by Dr. Reddy's Laboratories in 2023. Skoka is combining proprietary formulations, ingredient transparency and equity investment from professional athletes. The company submitted a bundled PMTA covering 55 products on October 1, 2026. Aziz said Skoka declined an opportunity to enter retail in 2025, prioritizing product research and regulatory submissions instead. It now targets a U.S. retail launch in 2027, subject to FDA requirements. Its products have not received marketing authorization.
Business
Nov.04
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana's Alcohol and Tobacco Commission (ATC) ordered tobacco certificate holders in September to remove certain vaping products marketed under Elf Bar, Lost Mary, MR FOG, iJOY and other brands from inventory under the state's foreign-adversary product law. The agency later listed 257 MR FOG products and 77 Lost Mary product entries as lawful for sale. The Lost Mary revision expressly stated that compliance evidence had been received for 20 additional products. 2Firsts compliance expert Kurt said potential filings could include e-liquid and ingredient-origin records, U.S. nicotine-analog supply-chain documentation and FDA premarket application status.
Regulations
Oct.08